Conducting clinical research studies with
Call to participate

Alzheimer’s Awareness

CCRstudies is a member of the Alzheimer's Foundation of America.

CCRstudies is a member of the Alzheimer’s Foundation of America.

November is National Alzheimer’s Awareness Month. Volunteers are needed for an Alzheimer’s study being conducted in New London by Dr. Laurence Radin, Dr. Edward McDermott, and Andrea Stewart, APRN.

Alzheimer’s disease is the most common form of dementia in adults 65 and over.  Dementia is a general term which describes a group of symptoms related to the loss of a variety of intellectual functions.  This can include loss in memory, judgment, language and complex motor skills which may interfere with daily living.

The Alzheimer’s Foundation of America notes that “Alzheimer’s disease is not a normal part of aging: however, age is the greatest known risk factor.  Other factors are genetic makeup and chronic untreated health problems such as high blood pressure.”

There is no cure currently available for Alzheimer’s disease, but there are FDA-approved medications available that can help to slow the progression of disease symptoms.

Research is currently underway in New London testing an investigational add-on medication for the treatment of Alzheimer’s. Volunteers with mild to moderate memory loss currently taking Aricept are needed as potential study volunteers. There has been no new medication introduced for the treatment of Alzheimer’s in over a decade.  If you or someone you know, ages 50 or above, is living with mild to moderate memory loss, you may qualify for this research study.  Call a member of the CCRstudies Team at 860-443-4567 today to learn more about how you can be involved in research.  Study participants and caregivers are eligible to receive compensation for their time and travel in addition to no cost study-related care.